메뉴 건너뛰기




Volumn 21, Issue 4, 2010, Pages 254-259

Mechanism of hemostasis defects and management of bleeding in patients with acute coronary syndromes

Author keywords

Acute coronary syndromes; Bleeding; Blood transfusion; Hemostatic agents

Indexed keywords

ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; ANTICOAGULANT AGENT; APROTININ; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; DESMOPRESSIN; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN INHIBITOR; TRANEXAMIC ACID; FIBRINOLYTIC AGENT;

EID: 77955334532     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.03.010     Document Type: Short Survey
Times cited : (6)

References (45)
  • 1
    • 70350568827 scopus 로고    scopus 로고
    • New antiplatelet agents: Why they are needed
    • M. Franchini, and P.M. Mannucci New antiplatelet agents: why they are needed Eur J Intern Med 20 2009 733 738
    • (2009) Eur J Intern Med , vol.20 , pp. 733-738
    • Franchini, M.1    Mannucci, P.M.2
  • 3
    • 0032560732 scopus 로고    scopus 로고
    • Hemostatic drugs
    • P.M. Mannucci Hemostatic drugs N Engl J Med 339 1998 245 253
    • (1998) N Engl J Med , vol.339 , pp. 245-253
    • Mannucci, P.M.1
  • 4
    • 34249821653 scopus 로고    scopus 로고
    • Prevention and treatment of major blood loss
    • P.M. Mannucci, and M. Levi Prevention and treatment of major blood loss N Engl J Med 356 2007 2301 2311
    • (2007) N Engl J Med , vol.356 , pp. 2301-2311
    • Mannucci, P.M.1    Levi, M.2
  • 5
    • 71749087343 scopus 로고    scopus 로고
    • Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: A retrospective analysis of nationwide registry data
    • R. Sorensen, M.L. Hansen, S.Z. Abildstrom, A. Hvelplund, C. Andersson, and C. Jorgensen Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data Lancet 374 2009 1967 1974
    • (2009) Lancet , vol.374 , pp. 1967-1974
    • Sorensen, R.1    Hansen, M.L.2    Abildstrom, S.Z.3    Hvelplund, A.4    Andersson, C.5    Jorgensen, C.6
  • 6
    • 29544437848 scopus 로고    scopus 로고
    • Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes
    • K.P. Alexander, A.Y. Chen, M.T. Roe, L.K. Newby, C.M. Gibson, and N.M. Allen-LaPointe Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes JAMA 294 2005 3108 3116
    • (2005) JAMA , vol.294 , pp. 3108-3116
    • Alexander, K.P.1    Chen, A.Y.2    Roe, M.T.3    Newby, L.K.4    Gibson, C.M.5    Allen-Lapointe, N.M.6
  • 7
    • 68749096118 scopus 로고    scopus 로고
    • Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction
    • P. Willis, and M.D. Voeltz Anemia, hemorrhage, and transfusion in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction Am J Cardiol 104 2009 34C 38C Suppl
    • (2009) Am J Cardiol , vol.104
    • Willis, P.1    Voeltz, M.D.2
  • 8
    • 33747599590 scopus 로고    scopus 로고
    • Adverse impact of bleeding on prognosis in patients with acute coronary syndromes
    • J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
    • (2006) Circulation , vol.114 , pp. 774-782
    • Eikelboom, J.W.1    Mehta, S.R.2    Anand, S.S.3    Xie, C.4    Fox, K.A.5    Yusuf, S.6
  • 9
    • 68249154903 scopus 로고    scopus 로고
    • Clinical implications and management of bleeding events in patients with acute coronary syndromes
    • L. De Luca, G. Casella, M. Lettino, G. Fradella, V. Toschi, and M.R. Conte Clinical implications and management of bleeding events in patients with acute coronary syndromes J Cardiovasc Med 10 2009 677 686
    • (2009) J Cardiovasc Med , vol.10 , pp. 677-686
    • De Luca, L.1    Casella, G.2    Lettino, M.3    Fradella, G.4    Toschi, V.5    Conte, M.R.6
  • 11
    • 34547801673 scopus 로고    scopus 로고
    • Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes
    • S.V. Rao, J.A. Eikelboom, C.B. Granger, R.A. Harrington, R.M. Califf, and J.P. Bassand Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1193 1204
    • (2007) Eur Heart J , vol.28 , pp. 1193-1204
    • Rao, S.V.1    Eikelboom, J.A.2    Granger, C.B.3    Harrington, R.A.4    Califf, R.M.5    Bassand, J.P.6
  • 12
    • 37349125565 scopus 로고    scopus 로고
    • Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?
    • F.A. Spencer, M. Moscucci, C.B. Granger, J.M. Gore, R.J. Goldberg, and P.G. Steg Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 116 2007 2793 2801
    • (2007) Circulation , vol.116 , pp. 2793-2801
    • Spencer, F.A.1    Moscucci, M.2    Granger, C.B.3    Gore, J.M.4    Goldberg, R.J.5    Steg, P.G.6
  • 13
    • 38949108302 scopus 로고    scopus 로고
    • Percutaneous coronary intervention pharmacology: From a triangle to a square
    • H.L. Dauerman Percutaneous coronary intervention pharmacology: from a triangle to a square J Am Coll Cardiol 51 2008 698 700
    • (2008) J Am Coll Cardiol , vol.51 , pp. 698-700
    • Dauerman, H.L.1
  • 14
    • 4644350897 scopus 로고    scopus 로고
    • Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes
    • S.V. Rao, J.G. Jollis, R.A. Harrington, C.B. Granger, L.K. Newby, and P.W. Armstrong Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562
    • (2004) JAMA , vol.292 , pp. 1555-1562
    • Rao, S.V.1    Jollis, J.G.2    Harrington, R.A.3    Granger, C.B.4    Newby, L.K.5    Armstrong, P.W.6
  • 17
    • 0026528014 scopus 로고
    • Prudent strategies for elective red blood cell transfusion
    • H.G. Welch, K.R. Meenhan, and L.T. Goodnough Prudent strategies for elective red blood cell transfusion Ann Intern Med 116 1992 393 402
    • (1992) Ann Intern Med , vol.116 , pp. 393-402
    • Welch, H.G.1    Meenhan, K.R.2    Goodnough, L.T.3
  • 19
    • 0031937028 scopus 로고    scopus 로고
    • Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: A randomized clinical trial
    • L.M.G. van de Watering, J. Hermans, J.G. Houbiers, P.J. van den Broek, H. Bouter, and F. Boer Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial Circulation 97 1998 5562 5568
    • (1998) Circulation , vol.97 , pp. 5562-5568
    • Van De Watering, L.M.G.1    Hermans, J.2    Houbiers, J.G.3    Van Den Broek, P.J.4    Bouter, H.5    Boer, F.6
  • 20
    • 2942587148 scopus 로고    scopus 로고
    • Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery
    • Y.M. Bilgin, L.M. van de Watering, L. Eijsman, M.I. Versteegh, R. Brand, and M.H. van Oers Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery Circulation 109 2004 2755 2760
    • (2004) Circulation , vol.109 , pp. 2755-2760
    • Bilgin, Y.M.1    Van De Watering, L.M.2    Eijsman, L.3    Versteegh, M.I.4    Brand, R.5    Van Oers, M.H.6
  • 21
    • 65349166375 scopus 로고    scopus 로고
    • Transfusion-related mortality: The ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
    • E.C. Vamvakas, and M.A. Blajchman Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention Blood 113 2009 3406 3417
    • (2009) Blood , vol.113 , pp. 3406-3417
    • Vamvakas, E.C.1    Blajchman, M.A.2
  • 22
    • 65549123030 scopus 로고    scopus 로고
    • Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score
    • S. Subherwal, R.G. Bach, A.Y. Chen, B.F. Gage, S.V. Rao, and L.K. Newby Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score Circulation 119 2009 1873 1882
    • (2009) Circulation , vol.119 , pp. 1873-1882
    • Subherwal, S.1    Bach, R.G.2    Chen, A.Y.3    Gage, B.F.4    Rao, S.V.5    Newby, L.K.6
  • 23
    • 45949098057 scopus 로고    scopus 로고
    • Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
    • S. Schulman, Kearon C. Beyth RJ, and M.N. Levine Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 Suppl. 6 2008 257S 298S
    • (2008) Chest , vol.133 , Issue.SUPPL. 6
    • Schulman, S.1    Beyth, R.J.K.C.2    Levine, M.N.3
  • 24
    • 3042782723 scopus 로고    scopus 로고
    • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: Primary results of the SYNERGY randomized trial
    • J.J. Ferguson, R.M. Califf, E.M. Antman, M. Cohen, C.L. Grines, and S. Goodman Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial JAMA 292 2004 45 54
    • (2004) JAMA , vol.292 , pp. 45-54
    • Ferguson, J.J.1    Califf, R.M.2    Antman, E.M.3    Cohen, M.4    Grines, C.L.5    Goodman, S.6
  • 28
    • 0001074389 scopus 로고
    • Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid
    • L. Andersson, I.M. Nilsson, J.E. Nilehn, U. Hedner, B. Granstrand, and B. Melander Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-aminomethyl cyclohexane carboxylic acid Scand J Haematol 2 1965 230 247
    • (1965) Scand J Haematol , vol.2 , pp. 230-247
    • Andersson, L.1    Nilsson, I.M.2    Nilehn, J.E.3    Hedner, U.4    Granstrand, B.5    Melander, B.6
  • 29
    • 0016742118 scopus 로고
    • Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids
    • S. Thorsen Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation. Influence of omega-aminocarboxylic acids Biochim Biophys Acta 393 1975 55 65
    • (1975) Biochim Biophys Acta , vol.393 , pp. 55-65
    • Thorsen, S.1
  • 31
    • 0020678186 scopus 로고
    • Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs
    • H. Fritz, and G. Wunderer Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs Arzneimittelforschung 33 1983 479 494
    • (1983) Arzneimittelforschung , vol.33 , pp. 479-494
    • Fritz, H.1    Wunderer, G.2
  • 32
    • 0024811381 scopus 로고
    • Aprotinin concentrations effective for the inhibition of tissue kallikrein and plasma kallikrein in vitro and in vivo
    • H. Hoffmann, M. Siebeck, O. Thetter, M. Jochum, and H. Fritz Aprotinin concentrations effective for the inhibition of tissue kallikrein and plasma kallikrein in vitro and in vivo Adv Exp Med Biol 247B 1989 35 42
    • (1989) Adv Exp Med Biol , vol.247 , pp. 35-42
    • Hoffmann, H.1    Siebeck, M.2    Thetter, O.3    Jochum, M.4    Fritz, H.5
  • 34
    • 58849137661 scopus 로고    scopus 로고
    • The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: A meta-analysis
    • D. Henry, P. Carless, D. Fergusson, and A. Laupacis The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis CMAJ 180 2009 183 193
    • (2009) CMAJ , vol.180 , pp. 183-193
    • Henry, D.1    Carless, P.2    Fergusson, D.3    Laupacis, A.4
  • 35
    • 37449034020 scopus 로고    scopus 로고
    • The use of desmopressin in open-heart surgery
    • M. Cattaneo The use of desmopressin in open-heart surgery Haemophilia 14 S1 2008 40 47
    • (2008) Haemophilia , vol.14 , Issue.S1 , pp. 40-47
    • Cattaneo, M.1
  • 36
    • 0028885045 scopus 로고
    • The effect of desmopressin on reducing blood loss in cardiac surgery - A meta-analysis of double-blind, placebo-controlled trials
    • M. Cattaneo, A.S. Harris, U. Stromberg, and P.M. Mannucci The effect of desmopressin on reducing blood loss in cardiac surgery - a meta-analysis of double-blind, placebo-controlled trials Thromb Haemost 74 1995 1064 1070
    • (1995) Thromb Haemost , vol.74 , pp. 1064-1070
    • Cattaneo, M.1    Harris, A.S.2    Stromberg, U.3    Mannucci, P.M.4
  • 37
    • 0028079871 scopus 로고
    • Meta-analysis of prophylactic drug treatment in the prevention of postoperative bleeding
    • S.E. Fremes, B.I. Wong, E. Lee, R. Mai, G.T. Christakis, and R. Mc Lean Meta-analysis of prophylactic drug treatment in the prevention of postoperative bleeding Ann Thorac Surg 58 1994 1580 1588
    • (1994) Ann Thorac Surg , vol.58 , pp. 1580-1588
    • Fremes, S.E.1    Wong, B.I.2    Lee, E.3    Mai, R.4    Christakis, G.T.5    Mc Lean, R.6
  • 38
    • 0033524140 scopus 로고    scopus 로고
    • Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints
    • M. Levi, M.E. Cromheecke, E. de Jonge, M.H. Prins, B.J. de Mol, and E. Briët Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints Lancet 354 1999 1940 1947
    • (1999) Lancet , vol.354 , pp. 1940-1947
    • Levi, M.1    Cromheecke, M.E.2    De Jonge, E.3    Prins, M.H.4    De Mol, B.J.5    Briët, E.6
  • 39
    • 10244270631 scopus 로고    scopus 로고
    • The use of recombinant factor VIIa in the treatment of bleeding disorders
    • H.R. Roberts, D.M. Monroe, and G.C. White The use of recombinant factor VIIa in the treatment of bleeding disorders Blood 104 2004 3858 3864
    • (2004) Blood , vol.104 , pp. 3858-3864
    • Roberts, H.R.1    Monroe, D.M.2    White, G.C.3
  • 40
    • 0036464599 scopus 로고    scopus 로고
    • Mechanism of factor VIIa-dependent coagulation in hemophilia blood
    • S. Butenas, K.E. Brummel, R.F. Branda, S.G. Paradis, and K.G. Mann Mechanism of factor VIIa-dependent coagulation in hemophilia blood Blood 99 2002 923 930
    • (2002) Blood , vol.99 , pp. 923-930
    • Butenas, S.1    Brummel, K.E.2    Branda, R.F.3    Paradis, S.G.4    Mann, K.G.5
  • 41
    • 0027302704 scopus 로고
    • The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor
    • H. ten Cate, K.A. Bauer, M. Levi, T.S. Edgington, R.D. Sublett, and S. Barzegar The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor J Clin Invest 92 1993 1207 1212
    • (1993) J Clin Invest , vol.92 , pp. 1207-1212
    • Ten Cate, H.1    Bauer, K.A.2    Levi, M.3    Edgington, T.S.4    Sublett, R.D.5    Barzegar, S.6
  • 42
    • 0036090268 scopus 로고    scopus 로고
    • Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A
    • T. Lisman, L.O. Mosnier, T. Lambert, E.P. Mauser-Bunschoten, J.C. Meijers, and H.K. Nieuwenhuis Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A Blood 99 2002 175 179
    • (2002) Blood , vol.99 , pp. 175-179
    • Lisman, T.1    Mosnier, L.O.2    Lambert, T.3    Mauser-Bunschoten, E.P.4    Meijers, J.C.5    Nieuwenhuis, H.K.6
  • 43
    • 17044405174 scopus 로고    scopus 로고
    • Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review
    • M. Levi, M. Peters, and H.R. Buller Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review Crit Care Med 33 2005 883 890
    • (2005) Crit Care Med , vol.33 , pp. 883-890
    • Levi, M.1    Peters, M.2    Buller, H.R.3
  • 44
    • 33747193523 scopus 로고    scopus 로고
    • Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation
    • R. Altman, A. Scazziota, M. De Lourdes Herrera, and C. Gonzalez Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation J Thromb Haemost 4 2006 2022 2027
    • (2006) J Thromb Haemost , vol.4 , pp. 2022-2027
    • Altman, R.1    Scazziota, A.2    De Lourdes Herrera, M.3    Gonzalez, C.4
  • 45
    • 34250193640 scopus 로고    scopus 로고
    • The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders
    • M.C. Poon The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders Transfus Med Rev 21 2007 223 236
    • (2007) Transfus Med Rev , vol.21 , pp. 223-236
    • Poon, M.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.